The effectiveness of orally administered triamcinolone in 60% of the cases treated was first reported by Shelley and colleagues1in a series of 60 patients with psoriasis. Of 21 of these patients who had skin tests in a psoriatic lesion with a 1% suspension of triamcinolone, 11 showed a zone of clearing at the injection site. Subsequently one of us (R. L. B.) with Cohen2demonstrated that triamcinolone in suspension injected intradermally produced larger zones of clearing in